MSN MoneyCentral - Tercica, Inc. TRCA today announced that the Company has begun dosing the first patient in a Phase II clinical study evaluating the combination of Genentech, Inc.'s recombinant human growth hormone Nutropin AQ(R) (somatropin (rDNA origin)) and Tercica ...
- Recent posts
- House committee issues subpoena to former Yankee Chuck Knoblauch
- Tercica Starts Phase II Clinical Trial With Next-Generation Growth ...
- Tercica Initiates Phase II Clinical Trial with Next-Generation Growth ...
- Why We Love Justice (and Shouldn't)
- House committee issues subpoena to former Yankee Chuck Knoblauch
- Metabolic Control and Growth during Exclusive Growth Hormone...
- Cyclists in Amgen Tour of California will face stringent anti-doping ...
- Even Celebrities Aren't Safe From The Human Growth Hormone Hunt
- Human Growth Hormone, buy Human Growth Hormone, cheap hgh
- Lowell: Baseball held to higher standard
- ROGER'S PREEMPTIVE STRIKE
- Clemens, Pettitte asked to testify before Congress
- Sports at 2:15 p.m.
- Roger Clemens throws a slider: admits to injections
- Memo to Roger, We Can Handle the Truth
- Phil Sheridan | Is Roger a dodger? We'll see
- Rocket, trainer reportedly have ‘emotional’ talk
- Let's get serious about steroids
- Owners should think twice before signing pitchers to long-term deals
- Postcards from the Ledge: There can be no denying that Clemens ...